Abstract
| Original language | English |
|---|---|
| Pages (from-to) | 129-141 |
| Number of pages | 13 |
| Journal | Journal of Community Genetics |
| Volume | 10 |
| Issue number | 1 |
| Early online date | 14 Jun 2018 |
| DOIs | |
| Publication status | Published - Jan 2019 |
Fingerprint
Keywords
- Familial hypercholesterolemia (FH)
- Parents
- Children
- Treatment
- Qualitative interviews
Cite this
Parents’ views of genetic testing and treatment of familial hypercholesterolemia in children : a qualitative study. / Keenan, Karen Forrest (Corresponding Author); Finnie, Robert M.; Simpson, William G.; McKee, Lorna; Dean, John; Miedzybrodzka, Zosia.
In: Journal of Community Genetics, Vol. 10, No. 1, 01.2019, p. 129-141.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Parents’ views of genetic testing and treatment of familial hypercholesterolemia in children
T2 - a qualitative study
AU - Keenan, Karen Forrest
AU - Finnie, Robert M.
AU - Simpson, William G.
AU - McKee, Lorna
AU - Dean, John
AU - Miedzybrodzka, Zosia
N1 - Open Access via Springer Compact Agreement. We would like to thank all the participants who took part and the genetics/lipid services who helped with recruitment, particularly Hazel Hailey and Margaretha van Mourik. We also thank our project advisory team, patient representatives and Zoe Skea. KFK was supported by a Postdoctoral Fellowship from the Chief Scientist Office of the Scottish Government (PDF/10/06). The views of this paper are the authors own.
PY - 2019/1
Y1 - 2019/1
N2 - Familial hypercholesterolemia (FH) is a serious inherited disorder which greatly increases individuals’ risk of Cardiovascular Disease (CVD) in adult life. However, medical treatment and lifestyle adjustments can fully restore life expectancy. Whilst European guidance advises that where there is a known family mutation genetic testing is undertaken in early childhood, the majority of the at-risk population remain untested and undiagnosed. To date, only a small number of studies have explored parents’ and children’s experiences of testing and treatment for FH, and little is known about interactions between health professionals, parents and children in clinic settings. In this study, in-depth interviews were undertaken with parents who had attended a genetics and/or lipid clinic for FH with their children (n=17). A thematic analysis revealed four main themes: Undertaking early prevention, postponing treatment, parental concerns and the importance of the wider family context. The majority of parents supported genetic testing for FH in childhood. However, although some were very supportive of following early treatment recommendations, others expressed reluctance. Importantly, some parents were concerned that inappropriate information had been shared with their children, and wished that more time had been given to discuss how, when and what to tell in advance. Future research is needed to explore the long term outcomes for children who undertake genetic testing and early treatment for FH, and to trial interventions to improve the engagement, follow up and support of children who are at risk, or diagnosed, with this disorder.
AB - Familial hypercholesterolemia (FH) is a serious inherited disorder which greatly increases individuals’ risk of Cardiovascular Disease (CVD) in adult life. However, medical treatment and lifestyle adjustments can fully restore life expectancy. Whilst European guidance advises that where there is a known family mutation genetic testing is undertaken in early childhood, the majority of the at-risk population remain untested and undiagnosed. To date, only a small number of studies have explored parents’ and children’s experiences of testing and treatment for FH, and little is known about interactions between health professionals, parents and children in clinic settings. In this study, in-depth interviews were undertaken with parents who had attended a genetics and/or lipid clinic for FH with their children (n=17). A thematic analysis revealed four main themes: Undertaking early prevention, postponing treatment, parental concerns and the importance of the wider family context. The majority of parents supported genetic testing for FH in childhood. However, although some were very supportive of following early treatment recommendations, others expressed reluctance. Importantly, some parents were concerned that inappropriate information had been shared with their children, and wished that more time had been given to discuss how, when and what to tell in advance. Future research is needed to explore the long term outcomes for children who undertake genetic testing and early treatment for FH, and to trial interventions to improve the engagement, follow up and support of children who are at risk, or diagnosed, with this disorder.
KW - Familial hypercholesterolemia (FH)
KW - Parents
KW - Children
KW - Treatment
KW - Qualitative interviews
UR - http://www.mendeley.com/research/parents-views-genetic-testing-treatment-familial-hypercholesterolemia-children-qualitative-study
U2 - 10.1007/s12687-018-0373-5
DO - 10.1007/s12687-018-0373-5
M3 - Article
C2 - 29949065
VL - 10
SP - 129
EP - 141
JO - Journal of Community Genetics
JF - Journal of Community Genetics
SN - 1868-6001
IS - 1
ER -